Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
Authors
Keywords
-
Journal
BMC Medicine
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-21
DOI
10.1186/s12916-022-02288-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes
- (2021) Stefano Ciardullo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue
- (2020) Yongin Cho et al. Biomedicines
- MRI‐Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis
- (2020) Rohit Loomba HEPATOLOGY
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Pathophysiological importance of bile cholesterol reabsorption: hepatic NPC1L1-exacerbated steatosis and decreasing VLDL-TG secretion in mice fed a high-fat diet
- (2019) Yu Toyoda et al. Lipids in Health and Disease
- Targeting the gut-liver axis in liver disease
- (2017) Reiner Wiest et al. JOURNAL OF HEPATOLOGY
- Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis
- (2016) Da Hyun Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
- (2016) Kento Imajo et al. GASTROENTEROLOGY
- Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
- (2016) Jeffrey Cui et al. JOURNAL OF HEPATOLOGY
- The Role of Cholesterol in the Pathogenesis of NASH
- (2016) George N. Ioannou TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
- (2015) Rohit Loomba et al. HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism
- (2015) Emilie Catry et al. LIFE SCIENCES
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of ezetimibe on visceral fat in the metabolic syndrome: a randomised controlled study
- (2012) Hiroyuki Takase et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
- (2011) Savitha Subramanian et al. JOURNAL OF LIPID RESEARCH
- Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c
- (2010) P. Ferré et al. DIABETES OBESITY & METABOLISM
- Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
- (2010) Hyohun Park et al. JOURNAL OF GASTROENTEROLOGY
- Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet
- (2010) Tomonori Muraoka et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1−/− mice
- (2008) Eric D. Labonté et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now